Showing results (331-340 of 445) with videos related to
Sort By:
Pageof 45
JACC. Advances|June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of HypertensionNelson Wang, Phidias Rueter, Abdul Salam, et al.Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.Journal of Human Hypertension|February 21, 2024
The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke StudyLiping Huang, Qiang Li, Jason Hy Wu, et al.JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.Open Heart|December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertensionSimone Marschner, Mark D Huffman, Desi Quintans, et al.Journal of Human Hypertension|July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost capsCatherine G Derington, Kyle Tong, Joshua A Jacobs, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 25, 2026
Blood pressure lowering for the prevention of REcurrent stroke and Cardiovascular outcomes After acute intracerebral haemorrhage: protocol for an individual Participant data meta-analysis of randomised controlled trials (RECAP-ICH)M J Velasco, Yijie Gao, Shitian Li, et al.The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.Pageof 45